GFPT1 and pancreatic neoplasm: In conclusion, our study has identified aberrant expression of GFAT1 as an independent prognostic factor in our small number of pancreatic cancer patients, and GFAT1 expression could be integrated with pTNM stages to generate a nomogram to give a better risk stratification for pancreatic cancer patients with different prognosis.